Steatotic liver disease in people with human immunodeficiency virus: A narrative review of metabolic steatotic liver disorders

Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are increasingly recognized as relevant comorbidities among people living with human immunodeficiency virus (PLWH), even in the absence of viral hepatitis coinfection or significant alcohol consumption. As life expectancy in PLWH improves, the burden of metabolic complications has become a major clinical concern. This narrative review explores the key risk factors implicat